Kyverna Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Kyverna Therapeutics, Inc. reported Common Stock Shares Outstanding of 60.39 million shares for the year ending 2025.

  • Kyverna Therapeutics, Inc. showed an increase of +39.7% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Kyverna Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Kyverna Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 4,730.8%.
  • Historical annual values: Fiscal year 2025: 60.39 million shares | Fiscal year 2024: 43.21 million shares | Fiscal year 2023: 1.25 million shares.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: